Found: 199
Select item for more details and to access through your institution.
Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of MAPT H1 and APOE 4 on transition from mild cognitive impairment to dementia.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Effect of MAPT H1 and APOE ℇ4 on Transition from Mild Cognitive Impairment to Dementia.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 4, p. 1065, doi. 10.3233/JAD-2010-101011
- By:
- Publication type:
- Article
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.840651
- By:
- Publication type:
- Article
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 5, p. 466, doi. 10.15252/emmm.201506123
- By:
- Publication type:
- Article
Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 7, p. 660, doi. 10.1002/emmm.201200243
- By:
- Publication type:
- Article
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 6115, doi. 10.1002/alz.14088
- By:
- Publication type:
- Article
Cortical microinfarcts in adults with Down syndrome assessed with 3T‐MRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 3906, doi. 10.1002/alz.13797
- By:
- Publication type:
- Article
Cognitive reserve in Down syndrome: a new opportunity to understand resilience in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074558
- By:
- Publication type:
- Article
Catalan Early Onset Dementia Network 2021 Report.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.070829
- By:
- Publication type:
- Article
To split or not to split: data‐driven components along the PPAOS‐PAA spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079020
- By:
- Publication type:
- Article
LC‐MS/MS‐based proteome profiling of CSF‐derived extracellular vesicles in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078953
- By:
- Publication type:
- Article
Biofluid markers of Alzheimer's disease‐associated CNS inflammation in adults with Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078993
- By:
- Publication type:
- Article
CSF proteome profiling identifies novel biomarkers for Frontotemporal Dementia and its pathological subtypes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078154
- By:
- Publication type:
- Article
Global analysis of synapse‐enriched miRNA in Alzheimer's disease temporal cortex post‐mortem.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076062
- By:
- Publication type:
- Article
Cross‐sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 9, p. 3916, doi. 10.1002/alz.13073
- By:
- Publication type:
- Article
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN‐derived networks and highlights causal links in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 8, p. 3350, doi. 10.1002/alz.12961
- By:
- Publication type:
- Article
Management of epilepsy in Alzheimer's disease in Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.059775
- By:
- Publication type:
- Article
Neuropathology of a patient with AD treated with low doses of verubecestat.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069556
- By:
- Publication type:
- Article
Plasma NfL associated neurodegeneration in adults with Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069410
- By:
- Publication type:
- Article
CSF proteome profiling reveals novel specific diagnostic biomarkers for Dementia with Lewy bodies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065449
- By:
- Publication type:
- Article
Thimet Oligopeptidase is a potential CSF biomarker for Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.065528
- By:
- Publication type:
- Article
Synaptic oligomeric Tau is an early event in tau‐affected brain regions in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.063598
- By:
- Publication type:
- Article
Transcriptome wide correlations with neuropathological hallmarks in the frontal cortex of FTLD patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.059619
- By:
- Publication type:
- Article
New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 2292, doi. 10.1002/alz.12643
- By:
- Publication type:
- Article
Characteristics of subjective cognitive decline associated with amyloid positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1832, doi. 10.1002/alz.12512
- By:
- Publication type:
- Article
State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 1, p. 159, doi. 10.1002/alz.12372
- By:
- Publication type:
- Article
Alzheimer's disease clinical onset and age at death in people with Down syndrome: A systematic review and population‐based study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055727
- By:
- Publication type:
- Article
Late‐onset epileptic seizures in adults with Down syndrome are linked to Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054986
- By:
- Publication type:
- Article
Neuropsychological correlates of plasma NfL in adults with Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052881
- By:
- Publication type:
- Article
Calsyntenin‐1 is a cerebrospinal fluid marker of frontotemporal dementia‐related synapse degeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057453
- By:
- Publication type:
- Article
Cortical microinfarcts along the Alzheimer's disease continuum in adults with Down syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056071
- By:
- Publication type:
- Article
Comparison of automated CLEIA and manual ELISA immunoassays for CSF AD biomarkers: The Fundació ACE Biomarker Research Program (FACEBREP).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051615
- By:
- Publication type:
- Article
Transcriptome‐wide characterization of the frontal cortex in FTLD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.049569
- By:
- Publication type:
- Article
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 10, p. 1628, doi. 10.1002/alz.12330
- By:
- Publication type:
- Article
AMYQ: An index to standardize quantitative amyloid load across PET tracers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 9, p. 1499, doi. 10.1002/alz.12317
- By:
- Publication type:
- Article
Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 4, p. 605, doi. 10.1002/alz.12229
- By:
- Publication type:
- Article
Blood‐based detection of early‐stage Alzheimer using multiomics and machine learning: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047334
- By:
- Publication type:
- Article
Exploring molecular biomarkers with potential prognostic value in longitudinal observational studies on Alzheimer's disease: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047017
- By:
- Publication type:
- Article
DNA methylation differences associated with peripheral biomarkers in the EMIF‐AD cohort: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045853
- By:
- Publication type:
- Article
VAMP2 is a cerebrospinal fluid marker of selective hippocampal synapse loss and episodic memory performance in Alzheimer's disease: Biomarkers (non‐neuroimaging) / Multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045268
- By:
- Publication type:
- Article
Which pre‐analytical confounder matters the most in the comparison of two cohorts? Tubes and storage fill volume put to the test: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045060
- By:
- Publication type:
- Article
Impact of cortical and subcortical atrophy in the diagnosis and prognosis of bvFTD: A multicenter longitudinal study: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044984
- By:
- Publication type:
- Article
Longitudinal plasma levels of neurofilament light in Down syndrome: A multicenter study: Biomarkers (non‐neuroimaging) / Longitudinal change over time.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044772
- By:
- Publication type:
- Article
<sup>1</sup>H‐MRS signature in Alzheimer disease in Down syndrome: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043346
- By:
- Publication type:
- Article
Transcriptome characterization of the motor cortex suggests microglial‐related key events due to TDP‐43 aberrant inclusions: Genetics: Molecular genetics of AD and ADRD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042953
- By:
- Publication type:
- Article
The effect of APOE ɛ4 in Alzheimer's disease biomarkers in Down syndrome: Neuroimaging: Other neurodegenerative disorders.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042889
- By:
- Publication type:
- Article